Alessandro Curioni

Vice-President, Europe and Africa; Director, IBM Research Europe

Dr. Alessandro Curioni is an IBM Fellow, Vice President of IBM Europe and Africa and Director of the IBM Research Lab in Zurich, Switzerland. He is responsible for IBM corporate research in Europe and leads IBM's global research strategies in Accelerated Discovery and Security.

Dr. Curioni is an internationally recognized leader in the area of high-performance computing and computational science, where his innovative thinking and seminal contributions have helped solve some of the most complex scientific and technological problems in healthcare, aerospace, consumer goods and electronics. He was a member of the winning team recognized with the prestigious Gordon Bell Prize in 2013 and 2015. His research interests now include AI, Big Data and novel compute paradigms, such as neuromorphic and quantum computing.

Dr. Curioni received his undergraduate degree in Theoretical Chemistry and his PhD from Scuola Normale Superiore, Pisa, Italy. He started at IBM Research – Zurich as a PhD student in 1993 before officially joining as a research staff member in 1998, where he had several research and manager roles, including being the founding manager of the Cognitive Computing and Computational Sciences department. He is a member of the Swiss Academy of Technical Sciences

Most Popular

Health and Healthcare Systems

AIと量子コンピューティングで抗生物質耐性に挑む

世界が新型コロナウイルスのパンデミック(世界的大流行)から立ち直りつつある今、新たなグローバル課題が影を落としています。それは、抗生物質耐性による危機です。世界各地で人々がマスクを外し、日常に「ソーシャル・ミキシング」が戻りつつある中、風邪の症状でパニックになる人もいるかもしれませんが、やみくもに抗生物質を飲むことは解決策にはなりません。抗生物質を飲めば飲むほど、細菌は抗...

28 Sep 2022

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum